Samsung Life Insurance Annual Conglomerate Disclosure – Assets of 309.9T KRW, Treasury Shares 10.21%, Neutral Event
Samsung Life Insurance total assets: 309,948.3B KRW, total liabilities: 253,531.5B KRW, total equity: 56,416.8B KRW, debt-to-equity ratio 449.39% (high due to insurance industry characteristics)
Out of 200 million shares, Lee Jae-yong (same person) holds 10.44%, Lee Bu-jin 5.76%, Lee Seo-hyun 1.15%; same-person side total 53.78% (including treasury shares 10.21%)
Samsung C&T is the largest shareholder with 19.34%; circular cross-shareholding continues (e.g., 7.49% stake in Samsung Electronics)
Board held ~60 meetings from May 2025 to April 2026; approved private fund investments and internal transactions with affiliates (goods/services, leases, IT services)
Total goods/services transactions with domestic affiliates: 156,651.5B KRW; major counterparties: Samsung Electronics, Samsung C&T, Samsung FN Real Estate
Transactions with public-interest foundations (Samsung Life Public Welfare Foundation, Samsung Medical Foundation, etc.): sales 918.6B KRW, purchases 5.7B KRW, other asset sales 0.48B KRW
Employees: 5,313; wholly or majority-owned financial subsidiaries include Samsung Asset Management, Samsung Card, Samsung Securities
No share buyback or cancellation disclosure; dividend record date set (Dec 16, 2025) but no specific amount provided
[AI Summary]This routine conglomerate disclosure is neutral, containing no capital changes or dividend increases affecting shareholder value directly. It confirms Samsung Life's solid financial base and intra-group shareholdings, but offers no material event for investment decision changes.
KOSPI Filing Information
Filing: Large Enterprise Group Status Disclosure [Annual And First Quarter Use (Individual Company)]